IGC Pharma, Inc. (IGC)
IGC Pharma, Inc. (NYSE American: IGC) is a clinical-stage biotech focused exclusively on Alzheimer’s disease (AD). Its lead candidate, IGC-AD1, targets agitation in Alzheimer’s dementia and is in a pivotal Phase 2 CALMA trial. Interim results show a 10.5-point greater reduction in agitation vs. p...